bariatry News
-
Ezisurg Medical presented at the European Bariatric Endoscopic Surgery Congress
On 23-24th September, 2021, the annual European Bariatric Endoscopic Surgery Trends (BEST) was successfully held in Montpellier, France. The BEST congress adopted a unique mode of online and offline access, bringing global experts and scholars together to discuss the cutting-edge progress in the field of bariatric surgery. Ezisurg Medical was honored to become the platinum partner of BEST, and ...
-
Blue Chip Medical Appoints Dorian Drake International as its Export Representative for Latin America and the Caribbean
Blue Chip Medical Products, Inc., a manufacturer of U.S.-made therapeutic mattresses and related patient safety products, has appointed Dorian Drake International as its exclusive export representative for Latin America and the Caribbean. Dorian Drake will as act as Blue Chip Medical’s sales and marketing arm in the region, with a special focus on developing distribution and promoting the ...
-
ReShape Lifesciences Receives USPTO Issue Notification for Patent Covering its ReShape Vest
ReShape Lifesciences Inc. (NASDAQ:RSLS), a developer of minimally invasive medical devices to treat obesity and metabolic diseases, today announces that the United States Patent and Trademark Office (“USPTO”) has issued an Issue Notification for U.S. Patent Number 10010441 entitled “Gastric Restriction Device for Treating Obesity,” which covers a patent application ...
-
ReShape Medical, Inc. Completes $38 Million Series D Financing
ReShape Medical® today announced that it has completed a Series D financing of $38 million led by HealthCor Partners Management, L.P. with participation from Endeavour Vision SA and existing investors, SV Life Sciences, New Leaf Venture Partners, U.S. Venture Partners and Venture Investors. The announcement follows the recent approval of the ReShape™ Integrated Dual Balloon System, a ...
-
ReShape Lifesciences Technologies to be Featured at Minimally Invasive Surgery Symposium
ReShape Lifesciences Inc. (NASDAQ:RSLS), a developer of minimally invasive medical devices to treat obesity and metabolic diseases, announced today that the Company and its products will be discussed during the Metabolic and Bariatric Sessions of the Minimally Invasive Surgery Symposium (MISS) taking place in Las Vegas from March 6-9, 2018. Details of the presentations are as follows: Friday, ...
-
Altimmune Announces Initiation Of 48-Week Phase 2 MOMENTUM Trial Of Pemvidutide In Obesity
Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that it has enrolled the first subject in the 48-week Phase 2 MOMENTUM trial evaluating the safety and efficacy of pemvidutide1 in subjects with obesity or overweight. Pemvidutide is a novel, investigational GLP-1/glucagon dual receptor agonist under development for the treatment of obesity and ...
-
How virtually `scrubbing in` could help surgeons hone their skills
There are a slew of digital health startups looking to change the surgical space to make it more connected, from Hillrom's surgical communication tool to Activ Surgical’s solution that gives surgeons real-time intraoperative visual data. London-based virtual surgery platform Proximie is looking to tackle surgical connectivity challenges with its augmented reality, machine learning and ...
-
ReShape Lifesciences Announces Stocking Order from Medical Supplier in Dubai
ReShape Lifesciences Inc. (NASDAQ:RSLS), a developer of minimally invasive medical devices to treat obesity and metabolic diseases announced today that it has received a significant order for its ReShape® Integrated Dual Balloon System from Al Zahrawi Medical a healthcare focused company specializing in medical, surgical, diagnostic and analytical lab and nuclear medicine supplies with ...
-
GI Dynamics Announces Final Data from the ENDO Trial, a Multicenter Study Demonstrating the Potential Use of EndoBarrier to Treat Type II Diabetes and Obesity.
Initial results show the duodenal jejunal bypass liner (DJBL) technology met overall glycemic control efficacy and SAE related device removal safety endpoints Findings Presented at DDW 2022 BOSTON – June 15, 2022 – GI Dynamics, a medical device company that is developing the EndoBarrier® System for patients diagnosed with type 2 diabetes and obesity, announced results from a ...
-
ReShape Lifesciences Announces 2017 Weight Loss Contest Winner
ReShape Lifesciences Inc. (NASDAQ:RSLS), a developer of minimally invasive medical devices to treat obesity and metabolic diseases, today announced the winners of its 2017 weight loss contest, which recognizes patients for their successful weight loss with the ReShape Balloon™. The contest winner lost a total of 80 pounds, or 41% total weight loss (TWL), with 60 pounds, or 28% TWL, lost ...
-
Activ Surgical Successfully Completes Institutional Review Board Study at University at Buffalo
BOSTON — May 24, 2022 — Activ Surgical™, a digital surgery pioneer, today announced the successful completion of an Institutional Review Board (IRB) study using its ActivSight™ intraoperative imaging module at the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo (UB) in New York. The 40-patient study was led by principal investigator Dr. ...
-
ReShape Lifesciences Receives FDA 510(k) Clearance for the GIBI HD Calibration Tubes for use in Gastric and Bariatric Procedures
New Calibration Tubes, in Three Sizes, Will Simplify Gastric and Bariatric Procedures Including Laparoscopic Sleeve Gastrectomy, Gastric Bypass and Gastric Banding Company to Introduce Product at IFSO 2022 World Congress in August; Sales to Commence in September ReShape Lifesciences (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced ...
-
CMR Surgical & Surgical Innovations develop new surgical hybrid port access system
CMR Surgical & Surgical Innovations develop new surgical hybrid port access system Surgical Innovations’ new YelloPort Elite™ 5mm, with reusable trocar and canula, reduces cost and waste generated when compared with traditional fully single use Port Access Systems Developed with CMR Surgical, the port access system is the latest addition to Surgical Innovation’s ...
-
Fractyl Health Provides Initial Clinical Update on Open-Label REVITA-T2Di
REVITA-T2Di is an open-label cohort evaluating Revita DMR® in patients with insulin-treated type 2 diabetes – Revita® in the T2Di cohort has been observed to be well tolerated and all patients previously on long-acting insulin have discontinued insulin therapy in the initial follow-up period – Regular updates on the extended follow-up of the REVITA-T2Di cohort in ...
-
Activ Surgical Completes First In-Human Procedures to Demonstrate Impact of its Surgical Intelligence and Sensing Platform
BOSTON — November 3, 2021 — Activ Surgical™, a digital surgery pioneer, today announced the completion of its first in-human surgery clinical trial utilizing the company’s technology-as-a-service bundle—the ActivInsights™ augment reality (AR)-based software suite and the ActivSight™ imaging module. Procedures for the study at The University of Texas ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you